The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients (Q92016726)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 April 2020
edit
Language Label Description Also known as
English
The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients
scientific article published on 17 April 2020

    Statements

    The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit